Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Natalie Boytsov"'
Autor:
Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Michel Delforge, Nirali Kotowsky, Jacopo Bitetti, Natalie Boytsov, Leena Camadoo-O'Byrne, Lindsey Powers Happ, Guillaume Germain, Ana Urosevic, Malena Mahendran, Mei Sheng Duh, Francois Laliberte, Michele Cavo, Hans C. Lee
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/3d1981ba586b47849c5e34cd418ff65a
Autor:
Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Michel Delforge, Nirali Kotowsky, Jacopo Bitetti, Natalie Boytsov, Leena Camadoo-O’byrne, Lindsey Powers Happ, Mujib Rohman, Guillaume Germain, Mei Sheng Duh, François Laliberté, Malena Mahendran, Ana Urosevic, Hans C. Lee
Publikováno v:
HemaSphere, Vol 7, p e20009f4 (2023)
Externí odkaz:
https://doaj.org/article/a182f50d2d1d418bb9ef6217311aeba2
Autor:
David Muram MD, Anna Kaltenboeck MA, Natalie Boytsov PhD, Eleanor Hayes-Larson MPH, Jasmina Ivanova MA, Howard G. Birnbaum PhD, Ralph Swindle PhD
Publikováno v:
American Journal of Men's Health, Vol 9 (2015)
Patterns of care following topical testosterone agent (TTA) initiation are poorly understood. This study aimed to characterize care following TTA initiation and compare results between patients with and without a serum testosterone (T) assay within 3
Externí odkaz:
https://doaj.org/article/9132fe2ffacf4115bab04562933581df
Autor:
Peter Feng Wang, Christopher W. Yee, Boris Gorsh, Miriam L. Zichlin, Prani Paka, Rachel H. Bhak, Natalie Boytsov, Anamika Khanal, Ahmed Noman, Maral DerSarkissian, Shannon Ferrante, Mei Sheng Duh
Publikováno v:
Leukemia & Lymphoma. 64:398-406
Patients with relapsed/refractory multiple myeloma (RRMM) resistant to multiple drug classes remain a high unmet need population. This longitudinal retrospective cohort study assessed real-world treatment patterns and outcomes in adults with RRMM. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105959b19d90ec6e9cf1e839a4a42d6e
https://doi.org/10.1080/10428194.2022.2140284
https://doi.org/10.1080/10428194.2022.2140284
Autor:
Joshua Richter, Peter Feng Wang, Alexa Molinari, Boris Gorsh, Natalie Boytsov, Suzanne Landi, Sue Perera, Prani Paka, Teresa Palumbo, Mei Sheng Duh, Christopher Yee, Anamika Khanal, Sonia Gupta, Ajai Chari
Publikováno v:
Blood. 140:4338-4340
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4af0c70b4128a6d8fbb1f21c72dce45d
https://doi.org/10.1182/blood-2022-164918
https://doi.org/10.1182/blood-2022-164918
Autor:
Malin Hultcrantz, David Kleinman, Ravi Vij, Fernando Escalante, Nirali Kotowsky, Jacopo Bitetti, Christine Mackay, Natalie Boytsov, Leena Camadoo-O'Byrne, Guillaume Germain, Mei Sheng Duh, François Laliberté, Malena Mahendran, Ana Urosevic, Hans C. Lee
Publikováno v:
Blood. 140:10124-10126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad5692eb504c6194d8219554a8c6dd2d
https://doi.org/10.1182/blood-2022-164929
https://doi.org/10.1182/blood-2022-164929
Autor:
Attaya Suvannasankha, Thomas W. LeBlanc, Julia R. Correll, Chloe Carmichael, Boris Gorsh, Mona Martin, Helen Kitchen, Laurie Eliason, Madeleine Thursfield, Natalie Boytsov, Eva Brown Hajdukova, Mary Beth Lewis, Christine Mackay, Prani Paka, Alicia O'Neill, Sue Perera, Shivaranjani Naine, Alexa Molinari, Maya Hanna, David Kleinman
Publikováno v:
Blood. 140:13264-13266
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a06e06ece3f807815dfd00ec10c410a1
https://doi.org/10.1182/blood-2022-159637
https://doi.org/10.1182/blood-2022-159637
Autor:
Laurie Batchelder, Stephanie Philpott, Victoria Divino, Natalie Boytsov, Eric M Maiese, Cosmina Hogea, Trudy Buckingham, Chi-Chang Chen, Ana Maria Rodriguez
Publikováno v:
Future oncology (London, England). 18(25)
Aim: This study aimed to assess physician preferences for later lines (third to fifth) of therapy in patients with relapsed/refractory multiple myeloma (RRMM) in the USA. Materials & methods: Factors relevant to physicians' treatment preferences for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::251d7385ed7606155305b2104d4fd60c
https://pubmed.ncbi.nlm.nih.gov/35801416
https://pubmed.ncbi.nlm.nih.gov/35801416
Publikováno v:
Blood. 140:12554-12555
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17b9b4066779010bc875ce02aa557e25
https://doi.org/10.1182/blood-2022-167184
https://doi.org/10.1182/blood-2022-167184
Publikováno v:
Advances in therapy. 39(5)
There is limited real-world evidence on the treatments for atopic dermatitis (AD) since dupilumab was approved in 2017. The objective of this study was to assess market share of drugs commonly prescribed for the treatment of AD and describe treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ee0446ab787ef477f9678a23066091
https://pubmed.ncbi.nlm.nih.gov/35287230
https://pubmed.ncbi.nlm.nih.gov/35287230